Gennex Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Gennex Laboratories Ltd. on BSE

Load latest

Gennex Laboratories Ltd.

01 Oct 2024

13.12

0.15%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we would like to inform you that the Company has received approval of its members by Special Resolutions passed in the 39th AGM of the Company held on September 30, 2024 for appointment of Mr. Dilip Raj Singhvi and Ms. Shilpa Bung as Independent (Non-Executive) Directors of the Company with effect from October 01, 2024 in place of retiring Independent (Non-Executive) Directors Mr. Y Ravinder Reddy and Ms Sadhana Bhansali whose current period of office has expired on the date of AGM i.e. September 30, 2024. The relevant details of the captioned appointment and retirement as per the requirements of Regulation 30 of SEBI (LODR) Regulations, 2015, read with SEBI circular No. 2023/123 dated July 13, 2023 are given in the enclosed Annexure A. We request you to take note of the above information on record and acknowledge the receipt of the same.

pdf

Gennex Laboratories Ltd.

30 Sep 2024

13.12

0.15%

AGM

GENNEX LABORATORIES LTD. - 531739 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to provide hereunder the proceedings of 39th AGM of the Company held on Monday September 30, 2024 through video conferencing (VC) / other Audio Visual means (OAVM). The meeting was held in compliance with various circulars issued by MCA and SEBI and other applicable provisions of the Companies Act, 2013 read with rules made thereunder. The meeting commenced at 12.30 Hrs and concluded at 13.05 Hrs. All the requisite Statutory Registers and other requisite documents were available electronically during the AGM for inspection by the members. This intimation is also uploaded in the Company website: www.gennexlab.com We request you to take the above information on record and acknowledge the receipt of the same.

pdf

Gennex Laboratories Ltd.

25 Sep 2024

13.12

0.15%

SAST

GENNEX LABORATORIES LTD. - 531739 - Closure of Trading Window

BSE India

Notice is hereby given that in pursuance of SEBI (PIT) Regulations, 2015 and Company''s code of conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the securities of the Company shall remain closed from October 01, 2024 till 48 hours after the public announcement through Board of Directors in their meeting held for announcing the Unaudited Financial Results for the Quarter and Half year ended on September 30, 2024 along with other matters for which trading window is required to be closed. The Board meeting date to approve the Unaudited Financial Results of the Company for the Quarter and Half year ended on September 30, 2024 will be informed in due course. All Promoters/designated/connected persons are advised not to trade in the securities of the company during aforesaid period of closure of Trading Window. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

11 Sep 2024

13.12

0.15%

Corp. Note

GENNEX LABORATORIES LTD. - 531739 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, we would like to inform you that the Company has issued Duplicate Share Certificate (s) in lieu of the Original Share Certificate (s) reported lost / misplaced, details whereof are attached herewith. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

09 Sep 2024

13.12

0.15%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Pursuant to Regulation 30 read with Part A Schedule III of SEBI (LODR) Regulations, 2015, we would like to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company approved the appointment of Mr. Mohammed Khaleequr Rahman as an Additional (Non-Executive) Director of the Company with effect from September 06, 2024, subject to approval of Shareholders of the Company. Mr. Mohammed Khaleequr Rahman will be Non-Executive Non-Independent Director and not related to Promoter or Promoter Group and fulfils the criteria as required under the provisions of the Companies Act, 2013 and rules framed thereunder and the Listing Regulations. The relevant details of the captioned appointment as per requirement of SEBI circular dated 13.07.2023 are given in Annexure A. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

09 Sep 2024

13.12

0.15%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper Publication of AGM Notice and eVoting related instructions advertisement cutting published in Business Standard and Saksham (Local) on September 07, 2024 for the 39th Annual General Meeting of the Company to be held at September 30, 2024. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

07 Sep 2024

13.12

0.15%

Corp. Note

GENNEX LABORATORIES LTD. - 531739 - Reg. 34 (1) Annual Report.

BSE India

we hereby submits the 39th Annual Report of Gennex Laboratories Limited ('the Company') for the Financial Year ended March 31, 2024, along with the Notice of the 39th Annual General Meeting to be held on September 30, 2024, have been sent electronically to the members who have registered their email ID as per the SEBI guideline. The aforesaid documents are available on the Company website i.e., www.gennexlab.com, and are also available for inspection at the Registered Office of the Company during office hours Further, inform you that U/Sec. 108 of the Companies Act, 2013 and the Rules, 2014, as amended, and Reg.44 of SEBI (LODR) Regulations, 2015, the Company is pleased to provide its member''s facility to exercise their right to vote on resolutions proposed to be passed in the AGM, by electronic means. The details as per the provisions of the Companies Act, 2013 are given in the attached Notice. This intimation is also uploaded on the Company website: www.gennexlab.com

pdf

Gennex Laboratories Ltd.

06 Sep 2024

13.12

0.15%

Corp. Action

GENNEX LABORATORIES LTD. - 531739 - Intimation Of Book Closure Of Gennex Laboratories Limited - BSE …

BSE India

Pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from September 23, 2024 to September 30, 2024 (both days inclusive) for the purpose of the 39th Annual General Meeting (AGM) to be held on Monday, September 30, 2024, for the financial year 2023-24. The intimation is also being uploaded on the Company website: www.gennexlab.com We request you to take the above information on record and acknowledge the receipt of the same.

pdf

Gennex Laboratories Ltd.

06 Sep 2024

13.12

0.15%

Board Meeting

GENNEX LABORATORIES LTD. - 531739 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Draft Directors''/ Board Report for the Financial Year March 31, 2024; 2. The 39th Annual General Meeting of the Company to be held on Monday, September 30, 2024 at 12:30 P.M.; 3. Secretarial Audit Report issued by Mr. Rakesh Kumar Gupta, Practicing Company Secretary, Kolkata; 4. Appointment of Ms. Ekta Goswami, Practicing Company Secretary, Kolkata as Scrutinizer for the AGM; 5. Book Closure Date in connection with 39th AGM between September 23, 2024 to September 30, 2024; 6. Appointment of Mr. Mohammed Khaleequr Rahman, as Additional Director (Non-Executive - Non Independent) of the Company. 7. Appointment of Mr. Rakesh Kumar Gupta, Practicing Company Secretary, Kolkata as a Secretarial Auditor for the Financial Year 2024-25. We hereby submit that the Board Meeting had commenced at 04:30 PM and concluded at 05:00 PM.

pdf

Gennex Laboratories Ltd.

28 Aug 2024

13.12

0.15%

Board Meeting

GENNEX LABORATORIES LTD. - 531739 - Board Meeting Intimation for Deciding The Conduct Of 39Th AGM …

BSE India

GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2024 ,inter alia, to consider and approve 1. To decide regarding the conduct of 39th AGM for the year ended March 31, 2024; 2. To Consider and Appoint Scrutinizer of the 39th Annual General Meeting in case of Finalisation of the Date of AGM; 3. Any other business with permission of the Chairperson.

pdf

Is Gennex Laboratories Ltd. worth buying?

126 Votes:

Buy 83.33%

Sell 6.35%

Hold 10.32%